Time |
Title |
Speaker |
10:00 - 10:05 (05') |
Opening Remark |
Kyu-Sung Lee Director, Research Institute for Future Medicine, Samsung Medical Center |
10:05 - 10:10 (05') |
Congratulatory address |
Seung Woo Park President of Samsung Medical Center |
10:10 - 10:15 (05') |
Congratulatory address |
Soon Koo Baik President of Wonju Severance Christian Hospital |
10:15 - 10:20 (05’) |
Congratulatory address |
미정 Ministry of Health and welfare |
10:20 - 10:30 (10') |
K-DEM Station: Current Status and Achievements |
Hong Jin Jeon Samsung Medical Center |
Session 1 |
Development and Commercialization of Digital Therapeutics (10:30 ~ 12:35) |
Chair : Hong Jin Jeon, Samsung Medical Center |
10:30 - 10:55 (25') |
Digital Therapeutics for Men’s Health - DiGA, Permanent approval |
미정CV 독일 Kranus Health |
10:55 - 11:20 (25') |
Development and Commercialization of Digital Therapeutics for CGM-based Automated Insulin Delivery |
Sang Man JinCV Professor, Samsung Medical Center |
11:20 - 11:45 (25') |
Clinical Application of Digital Therapeutics in Pediatric Allergic Diseases |
Kangmo AhnCV Professor, Samsung Medical Center |
11:45 - 12:10 (25’) |
Go-to-Market strategy of WELT-i (DTx for Insomnia) |
Seong-ji KangCV MD, MPH, WELT |
12:10 - 12:35 (25') |
Move and play, It will Diagnose and Treat MCI |
Sang Yeol YongCV Professor, Wonju Severance Christian Hospital |
12:35 - 13:30 (55') |
Break time / Lunch |
|
Session 2 |
Electroceuticals - Paradigm Shift in the Treatment of Chronic/Intractable Diseases (13:30 ~ 15:50) |
Chair : Young Min Shon, Samsung Medical Center |
13:30 - 13:55 (25') |
NaviNetics, Inc : Bench to Business to Bedside |
Kendall H., Lee, M.D., Ph.D.,CV Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics
Yoonbae Oh, Ph.D., CV Associate professor, Mayo Clinic & Vice president, NaviNetics
|
13:55 - 14:20 (25') |
Next-Generation Smart DBS and Neuromodulation: Elucidating Mechanism of Action of DBS in Drug Addiction |
Kendall H., Lee, M.D., Ph.D., CV Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics
Ho Jin Shin, Ph.D.CV Assistant Professor, Mayo Clinic
|
14:20 - 14:45 (25') |
Electroceuticals for Ocular Surface Diseases to Promote Nerve Function Recovery |
Dong Hui LimCV Professor, Samsung Medical Center |
14:45 - 15:10 (25') |
Analyzing Digital Biomarker of Neuromuscular Disorders for Personalized Electroceuticals |
Hooman LeeCV CEO, EXOSYSTEMS |
15:10 - 15:35 (25') |
Electroceuticals for Functional Recovery after Spinal Cord Injury |
Jung Keun HyunCV Professor, Dankook University Medical Center |
15:35 - 15:50 (15’) |
Break Time |
|
Session 3 |
Successful Market Entry Strategies for Digital & Electronic Therapeutics (15:50 ~ 17:30) |
Chair: Woo Seoun Huh, Samsung Medical Center |
15:50 - 16:10 (20') |
DTx Regulation and Successful Case |
Young Min HanCV Assistant Director, Ministry of Food and Drug Safety |
16:10 - 16:30 (20') |
Introduction to Reimbursement Coverage and Pricing Rules for DTx |
Yong Woo KimCV CEO, MDREX |
16:30 - 16:50 (20') |
Application of decentralized clinical trials of digital therapeutics |
Hae Sook BokCV Team Leader, A-CRO, Samsung Medical Center |
16:50 - 17:10 (20') |
Case Studies of Support for the Productization of Digital and Electronic Medical Devices |
Young-Jin KimCV Principal Researcher, Dept. of R&D, KBIOHEALTH |
17:10 - 17:30 (20') |
Differences between Digital Healthcare Services, Digital Therapeutics, and Telemedicine and Essential elements for Successful Market entry of Digital Treatment Devices |
Changheon OhCV CEO, Foresight Company Co. Ltd. |
CLOSING |